Investment Rating - The investment rating for the company is "Buy" (maintained) [1] Core Views - The company has shown significant revenue growth, with 2024 revenue reaching 4.465 billion yuan, a year-on-year increase of 19.15%, and a net profit of 394 million yuan, up 68.89% [5] - In Q1 2025, the company achieved revenue of 1.101 billion yuan, a year-on-year increase of 25.41%, and a net profit of 91 million yuan, up 62.13% [5] - The company is focusing on building its domestic brands, with a notable increase in profitability and a comprehensive profit structure optimization in its domestic business [7] Summary by Sections Recent Performance - The company's stock performance over the last 12 months has increased by 117.9%, significantly outperforming the CSI 300 index, which only increased by 7.5% [3] - The current stock price is 53.44 yuan, with a 52-week price range of 17.92 to 53.44 yuan [3] Revenue and Profitability - The company's overseas business revenue for 2024 was 3.051 billion yuan, a year-on-year increase of 14.61%, with a gross margin of 24.9% [7] - Domestic business revenue reached 1.414 billion yuan, a year-on-year increase of 30.2%, with a gross margin of 35.18% [7] - Pet food revenue was 2.471 billion yuan, up 5.1%, while pet canned food revenue was 662 million yuan, up 4.23% [7] - Pet staple food revenue surged to 1.107 billion yuan, a remarkable increase of 91.85% [7] Future Projections - Revenue projections for 2025-2027 are adjusted to 5.269 billion yuan, 6.437 billion yuan, and 7.849 billion yuan, respectively, with corresponding net profits of 449 million yuan, 555 million yuan, and 697 million yuan [9] - The company is expected to maintain a high growth rate in the pet sector, supported by a stable supply chain and continuous R&D capabilities [7]
中宠股份(002891):2024年报及2025一季报点评报告:业绩持续高增,聚焦国内自主品牌建设